دورية أكاديمية
Mediation of depressive symptoms in the association between blood urea nitrogen to creatinine ratio and cognition among middle-aged and elderly adults: evidence from a national longitudinal cohort study.
العنوان: | Mediation of depressive symptoms in the association between blood urea nitrogen to creatinine ratio and cognition among middle-aged and elderly adults: evidence from a national longitudinal cohort study. |
---|---|
المؤلفون: | Feng Q; The Second Clinical College of Guangzhou, University of Chinese Medicine, Guangzhou, China., Yang S; West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China., Ye S; The Second Clinical College of Guangzhou, University of Chinese Medicine, Guangzhou, China., Wan C; Brain Cognition and Brain Disease Institute, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China., Wang H; West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China., You J; Department of Cerebrovascular Disease, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China. youjs73@163.com. |
المصدر: | BMC psychiatry [BMC Psychiatry] 2024 Jul 19; Vol. 24 (1), pp. 515. Date of Electronic Publication: 2024 Jul 19. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: London : BioMed Central, [2001- |
مواضيع طبية MeSH: | Depression*/blood , Depression*/psychology , Creatinine*/blood , Cognition*/physiology , Blood Urea Nitrogen*, Humans ; Male ; Longitudinal Studies ; Female ; Aged ; Middle Aged ; China/epidemiology ; Mediation Analysis ; Cognitive Dysfunction/blood |
مستخلص: | Background: The relationships between BUNCr (blood urea nitrogen and creatinine ratio) and cognitive function, as well as depressive symptoms, remain unclear. We aim to investigate the association between BUNCr and cognition, as well as depressive symptoms, and to identify the mechanisms underlying these relationships. Methods: We utilized data from the China Health and Retirement Longitudinal Study (CHARLS) from 2015 to 2020. Cognitive function was assessed using the Telephone Interview of Cognitive Status (TICS) scale, while depressive symptoms were assessed using the 10-item Center for Epidemiologic Studies Depression Scale (CES-D-10). We employed multivariate linear regression models to examine the association between BUNCr and cognitive function, as well as depressive symptoms. Additionally, causal mediation analysis was conducted to identify potential mediation effects of depressive symptoms between BUNCr and cognition. Results: We observed a negative association between BUNCr and cognitive function (coefficient: -0.192; 95% confidence interval [CI]: -0.326 ∼ -0.059) and a positive relationship between BUNCr and depressive symptoms (coefficient: 0.145; 95% CI: 0.006 ∼ 0.285). In addition, the causal mediation analysis revealed that depressive symptoms (proportion mediated: 7.0%) significantly mediated the association between BUNCr and cognition. Conclusion: Our study has unveiled that BUNCr is inversely associated with cognitive function and positively linked to depressive symptoms. Moreover, we found that depressive symptoms significantly mediated the association between BUNCr and cognition. These findings provide new evidence and insights for the prevention and management of cognitive function and dementia. (© 2024. The Author(s).) |
References: | Exp Gerontol. 2022 Nov;169:111960. (PMID: 36152777) Am Fam Physician. 2000 Apr 1;61(7):2077-88. (PMID: 10779250) Int J Geriatr Psychiatry. 1999 Aug;14(8):608-17. (PMID: 10489651) Soc Sci Med. 2019 May;229:96-105. (PMID: 30274688) Brain Behav. 2020 Mar;10(3):e01542. (PMID: 31985179) Epidemiology. 2016 May;27(3):368-77. (PMID: 26841057) Lancet Public Health. 2022 Feb;7(2):e105-e125. (PMID: 34998485) Epidemiology. 1992 Mar;3(2):143-55. (PMID: 1576220) JAMA. 2019 Nov 5;322(17):1728. (PMID: 31688886) Front Neurosci. 2022 Nov 22;16:1064813. (PMID: 36483180) J Clin Med. 2022 Aug 29;11(17):. (PMID: 36078999) JAMA Neurol. 2020 Nov 1;77(11):1373-1381. (PMID: 32658246) BMC Cardiovasc Disord. 2022 Jun 8;22(1):258. (PMID: 35676647) JAMA Netw Open. 2019 Dec 2;2(12):e1916591. (PMID: 31800066) PLoS One. 2016 May 26;11(5):e0155902. (PMID: 27227649) Epidemiology. 2009 Jan;20(1):18-26. (PMID: 19234398) Metab Brain Dis. 2023 Apr;38(4):1311-1321. (PMID: 36642760) Lancet Neurol. 2019 Jan;18(1):88-106. (PMID: 30497964) Psychol Methods. 2010 Dec;15(4):309-34. (PMID: 20954780) Nat Rev Dis Primers. 2020 Aug 20;6(1):69. (PMID: 32820163) Ann Intern Med. 2020 Feb 4;172(3):226. (PMID: 32016329) Lancet Public Health. 2020 Dec;5(12):e661-e671. (PMID: 33271079) Alzheimers Dement. 2018 Apr;14(4):483-491. (PMID: 29433981) Sci Total Environ. 2023 Aug 15;886:163980. (PMID: 37150467) Psychol Med. 2013 Mar;43(3):471-81. (PMID: 22831756) J Mol Neurosci. 2012 Feb;46(2):362-72. (PMID: 21750947) Aging Clin Exp Res. 2023 Mar;35(3):581-589. (PMID: 36629995) BMC Geriatr. 2021 Jan 29;21(1):85. (PMID: 33514331) Aging Dis. 2018 Aug 1;9(4):706-715. (PMID: 30090658) Ann Intern Med. 1993 Sep 15;119(6):474-81. (PMID: 8357112) Psychopharmacology (Berl). 2010 Jul;210(4):453-69. (PMID: 20414766) Am J Epidemiol. 2019 Nov 1;188(11):1871-1877. (PMID: 31364691) Br J Psychiatry. 2016 Dec;209(6):460-468. (PMID: 27539296) J Clin Med. 2022 Nov 28;11(23):. (PMID: 36498609) Front Psychiatry. 2018 Apr 19;9:143. (PMID: 29725309) Lancet. 2022 Mar 5;399(10328):957-1022. (PMID: 35180424) EBioMedicine. 2019 Oct;48:478-490. (PMID: 31628020) Psychopharmacology (Berl). 2014 Oct;231(19):3871-7. (PMID: 24668036) Exp Ther Med. 2022 Nov 29;25(1):36. (PMID: 36569431) J Affect Disord. 2022 Apr 1;302:234-240. (PMID: 35090945) Am J Psychiatry. 2008 Jun;165(6):663-5. (PMID: 18519528) Lancet. 2014 Mar 8;383(9920):911-22. (PMID: 23992774) J Cardiol. 2023 Apr;81(4):397-403. (PMID: 36410590) J Pers Med. 2023 Jan 11;13(1):. (PMID: 36675803) J Am Geriatr Soc. 2020 Feb;68(2):337-345. (PMID: 31675113) Front Aging Neurosci. 2023 May 22;15:1130833. (PMID: 37284018) Int J Epidemiol. 2014 Feb;43(1):61-8. (PMID: 23243115) Front Endocrinol (Lausanne). 2022 Oct 27;13:985167. (PMID: 36387890) |
معلومات مُعتمدة: | 81774055 National Natural Science Foundation of China |
فهرسة مساهمة: | Keywords: Blood urea nitrogen; Cognition; Creatinine; Depressive symptoms; Mediation |
المشرفين على المادة: | AYI8EX34EU (Creatinine) |
تواريخ الأحداث: | Date Created: 20240719 Date Completed: 20240720 Latest Revision: 20240725 |
رمز التحديث: | 20240726 |
مُعرف محوري في PubMed: | PMC11264492 |
DOI: | 10.1186/s12888-024-05941-7 |
PMID: | 39030588 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1471-244X |
---|---|
DOI: | 10.1186/s12888-024-05941-7 |